Mercer Global Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,962
| Closed | -$482K | – | 2014 |
|
|
2022
Q3 | $482K | Buy |
1,962
+56
| +3% | +$13.8K | ﹤0.01% | 1156 |
|
|
2022
Q2 | $472K | Buy |
1,906
+603
| +46% | +$149K | ﹤0.01% | 1173 |
|
|
2022
Q1 | $432K | Buy |
1,303
+5
| +0.4% | +$1.66K | ﹤0.01% | 1301 |
|
|
2021
Q4 | $466K | Buy |
1,298
+42
| +3% | +$15.1K | ﹤0.01% | 1247 |
|
|
2021
Q3 | $409K | Sell |
1,256
-41
| -3% | -$13.4K | ﹤0.01% | 1280 |
|
|
2021
Q2 | $405K | Buy |
1,297
+70
| +6% | +$21.9K | ﹤0.01% | 1243 |
|
|
2021
Q1 | $391K | Buy |
1,227
+356
| +41% | +$113K | ﹤0.01% | 1193 |
|
|
2020
Q4 | $282K | Buy |
871
+50
| +6% | +$16.2K | ﹤0.01% | 1087 |
|
|
2020
Q3 | $227K | Buy |
+821
| New | +$227K | ﹤0.01% | 1069 |
|
|
2019
Q2 | – | Sell |
-870
| Closed | -$248K | – | 1200 |
|
|
2019
Q1 | $248K | Buy |
+870
| New | +$248K | 0.01% | 904 |
|